{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:42:57Z","timestamp":1785166977397,"version":"3.55.0"},"reference-count":268,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008494","name":"Vontobel (Switzerland)","doi-asserted-by":"publisher","award":["no number"],"award-info":[{"award-number":["no number"]}],"id":[{"id":"10.13039\/501100008494","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013850","name":"Helmut Horten Stiftung","doi-asserted-by":"publisher","award":["no number"],"award-info":[{"award-number":["no number"]}],"id":[{"id":"10.13039\/501100013850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Animal models of Alzheimer\u2019s disease amyloidosis that recapitulate cerebral amyloid-beta pathology have been widely used in preclinical research and have greatly enabled the mechanistic understanding of Alzheimer\u2019s disease and the development of therapeutics. Comprehensive deep phenotyping of the pathophysiological and biochemical features in these animal models is essential. Recent advances in positron emission tomography have allowed the non-invasive visualization of the alterations in the brain of animal models and in patients with Alzheimer\u2019s disease. These tools have facilitated our understanding of disease mechanisms and provided longitudinal monitoring of treatment effects in animal models of Alzheimer\u2019s disease amyloidosis. In this review, we focus on recent positron emission tomography studies of cerebral amyloid-beta accumulation, hypoglucose metabolism, synaptic and neurotransmitter receptor deficits (cholinergic and glutamatergic system), blood\u2013brain barrier impairment, and neuroinflammation (microgliosis and astrocytosis) in animal models of Alzheimer\u2019s disease amyloidosis. We further propose the emerging targets and tracers for reflecting the pathophysiological changes and discuss outstanding challenges in disease animal models and future outlook in the on-chip characterization of imaging biomarkers towards clinical translation.<\/jats:p>","DOI":"10.3390\/ph14111179","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T02:43:09Z","timestamp":1637289789000},"page":"1179","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Positron Emission Tomography in Animal Models of Alzheimer\u2019s Disease Amyloidosis: Translational Implications"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0793-2113","authenticated-orcid":false,"given":"Ruiqing","family":"Ni","sequence":"first","affiliation":[{"name":"Institute for Biomedical Engineering, ETH & University of Zurich, 8093 Zurich, Switzerland"},{"name":"Institute for Regenerative Medicine, University of Zurich, 8952 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"ref_1","unstructured":"Bhatt, J., Comas Herrera, A., Amico, F., Farina, N., Wong, J., Orange, J.B., Gaber, S., Knapp, M., Salcher-Konrad, M., and Stevens, M. (2019). The World Alzheimer Report 2019: Attitudes to Dementia, Alzheimer\u2019s Disease International."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-\u03b2 protein assembly in the brain impairs memory","volume":"440","author":"Koh","year":"2006","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1471-4159.2006.04157.x","article-title":"Monoclonal antibodies that target pathological assemblies of A\u03b2","volume":"100","author":"Lambert","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-\u03b2 protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s00259-020-05187-x","article-title":"Outcomes of clinical utility in amyloid-PET studies: State of art and future perspectives","volume":"48","author":"Perini","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","article-title":"Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias","volume":"19","author":"Arbizu","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Recommendations of the International Working Group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jalz.2019.02.004","article-title":"A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies","volume":"15","author":"Perani","year":"2019","journal-title":"Alzheimers Dement."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.embor.7400784","article-title":"Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology","volume":"7","author":"Radde","year":"2006","journal-title":"EMBO Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1523\/JNEUROSCI.23-26-08989.2003","article-title":"PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation","volume":"23","author":"Richards","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","article-title":"Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology","volume":"94","author":"Abramowski","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: Potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ni, R., Dean-Ben, X.L., Kirschenbaum, D., Rudin, M., Chen, Z., Crimi, A., Voigt, F.F., Nilsson, K.P.R., Helmchen, F., and Nitsch, R. (2020). Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer\u2019s disease amyloidosis models. bioRxiv.","DOI":"10.1101\/2020.02.25.964064"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer\u2019s disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat. Neurosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13024-020-00399-z","article-title":"Modeling the \u03b2-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer\u2019s disease","volume":"15","author":"Serneels","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"101004","DOI":"10.1016\/j.jbc.2021.101004","article-title":"A 3(rd) generation mouse model of Alzheimer\u2019s disease shows early and increased cored plaque pathology composed of wild-type human amyloid \u03b2 peptide","volume":"297","author":"Sato","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1038\/s41467-021-22624-z","article-title":"Generation of a humanized A\u03b2 expressing mouse demonstrating aspects of Alzheimer\u2019s disease-like pathology","volume":"12","author":"Forner","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jalz.2018.06.3057","article-title":"A nonhuman primate model of early Alzheimer\u2019s disease pathologic change: Implications for disease pathogenesis","volume":"15","author":"Latimer","year":"2019","journal-title":"Alzheimer Dement."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/cne.24555","article-title":"Whole brain imaging reveals distinct spatial patterns of amyloid beta deposition in three mouse models of Alzheimer\u2019s disease","volume":"527","author":"Whitesell","year":"2019","journal-title":"J. Comp. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3233\/JAD-161027","article-title":"Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-\u03b2 Protein Precursor Transgenic Mice","volume":"56","author":"Liu","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.15252\/embj.201797397","article-title":"APP mouse models for Alzheimer\u2019s disease preclinical studies","volume":"36","author":"Sasaguri","year":"2017","journal-title":"EMBO J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1523\/JNEUROSCI.3854-05.2006","article-title":"Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease","volume":"26","author":"Robbins","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1042\/CS20170033","article-title":"Animal models of cerebral amyloid angiopathy","volume":"131","author":"Nicoll","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ni, R., Chen, Z., Shi, G., Villois, A., Zhou, Q., Arosio, P., Nitsch, R.M., Nilsson, K.P.R., Klohs, J., and Razansky, D. (2020). Transcranial in vivo detection of amyloid-beta at single plaque resolution with large-field multifocal illumination fluorescence microscopy. bioRxiv.","DOI":"10.1101\/2020.02.01.929844"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1016\/j.bmcl.2010.08.016","article-title":"A novel 18F-labeled pyridyl benzofuran derivative for imaging of \u03b2-amyloid plaques in Alzheimer\u2019s brains","volume":"20","author":"Cheng","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.nucmedbio.2011.04.004","article-title":"[18F]Fluoroazabenzoxazoles as potential amyloid plaque PET tracers: Synthesis and in vivo evaluation in rhesus monkey","volume":"38","author":"Hostetler","year":"2011","journal-title":"Nucl. Med. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neurobiolaging.2017.05.008","article-title":"Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model","volume":"57","author":"Snellman","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5272014","DOI":"10.1155\/2018\/5272014","article-title":"Early Detection of A\u03b2 Deposition in the 5xFAD Mouse by Amyloid PET","volume":"2018","author":"Oh","year":"2018","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1021\/acs.molpharmaceut.7b00351","article-title":"Preliminary PET Study of 18F-FC119S in Normal and Alzheimer\u2019s Disease Models","volume":"14","author":"Oh","year":"2017","journal-title":"Mol. Pharm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13550-015-0090-6","article-title":"FIBT versus florbetaben and PiB: A preclinical comparison study with amyloid-PET in transgenic mice","volume":"5","author":"Yousefi","year":"2015","journal-title":"EJNMMI Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00259-012-2178-9","article-title":"Pharmacokinetics of [18F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer\u2019s disease","volume":"39","author":"Snellman","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13550-014-0037-3","article-title":"In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer\u2019s disease with a high specific activity PET imaging agent [18F]flutemetamol","volume":"4","author":"Snellman","year":"2014","journal-title":"EJNMMI Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.1039\/D0SC02641G","article-title":"Metal-chelating benzothiazole multifunctional compounds for the modulation and 64Cu PET imaging of A\u03b2 aggregation","volume":"11","author":"Huang","year":"2020","journal-title":"Chem. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Xu, M., Guo, J., Gu, J., Zhang, L., Liu, Z., Ding, L., Fu, H., Ma, Y., Liang, S., and Wang, H. (2021). Preclinical and clinical study on [18F]DRKXH1: A novel \u03b2-amyloid PET tracer for Alzheimer\u2019s disease. Eur. J. Nucl. Med. Mol. Imaging, 1\u201312.","DOI":"10.1007\/s00259-021-05421-0"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1021\/acschemneuro.5b00055","article-title":"PET neuroimaging studies of [18F]CABS13 in a double transgenic mouse model of Alzheimer\u2019s disease and nonhuman primates","volume":"6","author":"Liang","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1471-4159.2010.06812.x","article-title":"Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand","volume":"114","author":"Swahn","year":"2010","journal-title":"J. Neurochem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"12263","DOI":"10.1523\/JNEUROSCI.1346-17.2017","article-title":"Multimodal Imaging in Rat Model Recapitulates Alzheimer\u2019s Disease Biomarkers Abnormalities","volume":"37","author":"Parent","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"30928","DOI":"10.1073\/pnas.2014058117","article-title":"Design of a multivalent bifunctional chelator for diagnostic (64)Cu PET imaging in Alzheimer\u2019s disease","volume":"117","author":"Cho","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"100285","DOI":"10.1016\/j.pacs.2021.100285","article-title":"In-vitro and in-vivo characterization of CRANAD-2 for multi-spectral optoacoustic tomography and fluorescence imaging of amyloid-beta deposits in Alzheimer mice","volume":"23","author":"Ni","year":"2021","journal-title":"Photoacoustics"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jalz.2016.08.006","article-title":"Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer\u2019s disease","volume":"13","author":"Ni","year":"2017","journal-title":"Alzheimer Dement."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3233\/JAD-201344","article-title":"In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer\u2019s Brain Tissue","volume":"80","author":"Ni","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.2967\/jnumed.112.110163","article-title":"Longitudinal amyloid imaging in mouse brain with 11C-PIB: Comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease","volume":"54","author":"Snellman","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Brendel, M., Jaworska, A., Grie\u00dfinger, E., R\u00f6tzer, C., Burgold, S., Gildehaus, F.J., Carlsen, J., Cumming, P., Baumann, K., and Haass, C. (2015). Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116678"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12868-018-0447-7","article-title":"Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer\u2019s disease with PET imaging agents 18F-flutemetamol and 18F-florbetaben","volume":"19","author":"Son","year":"2018","journal-title":"BMC Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40336-014-0098-3","article-title":"Amyloid PET imaging: Applications beyond Alzheimer\u2019s disease","volume":"3","author":"Catafau","year":"2015","journal-title":"Clin. Transl. Imaging"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1750-1326-6-86","article-title":"Resorufin analogs preferentially bind cerebrovascular amyloid: Potential use as imaging ligands for cerebral amyloid angiopathy","volume":"6","author":"Han","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nucmedbio.2020.05.001","article-title":"Development of a PET radioligand selective for cerebral amyloid angiopathy","volume":"92","author":"Abrahamson","year":"2021","journal-title":"Nucl. Med. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Biechele, G., Sebastian Monasor, L., Wind, K., Blume, T., Parhizkar, S., Arzberger, T., Sacher, C., Beyer, L., Eckenweber, F., and Gildehaus, F.J. (2021). Glitter in the Darkness? Non-fibrillar \u03b2-amyloid Plaque Components Significantly Impact the \u03b2-amyloid PET Signal in Mouse Models of Alzheimer\u2019s Disease. J. Nucl. Med., 62.","DOI":"10.1002\/alz.051983"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Meier, S.R., Sehlin, D., Roshanbin, S., Lim Falk, V., Saito, T., Saido, T.C., Neumann, U., Rokka, J., Eriksson, J., and Syvanen, S. (2021). 11C-PIB and 124I-antibody PET provide differing estimates of brain amyloid-beta after therapeutic intervention. J. Nucl. Med., 62.","DOI":"10.2967\/jnumed.121.262083"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/mp.2015.74","article-title":"Amyloid-PET predicts inhibition of de novo plaque formation upon chronic \u03b3-secretase modulator treatment","volume":"20","author":"Brendel","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.7150\/thno.27868","article-title":"Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional A\u03b2 deposition rate and plaque burden at treatment initiation","volume":"8","author":"Brendel","year":"2018","journal-title":"Theranostics"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2967\/jnumed.116.187625","article-title":"Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease","volume":"58","author":"Deleye","year":"2017","journal-title":"J. Nucl. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e20182266","DOI":"10.1084\/jem.20182266","article-title":"Molecular imaging of Alzheimer\u2019s disease\u2013related gamma-secretase in mice and nonhuman primates","volume":"217","author":"Xu","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00259-005-1780-5","article-title":"PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer\u2019s disease","volume":"32","author":"Toyama","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.neurobiolaging.2012.12.027","article-title":"In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography","volume":"34","author":"Rojas","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"10598","DOI":"10.1523\/JNEUROSCI.2990-05.2005","article-title":"Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer\u2019s disease brain but not in transgenic mouse brain","volume":"25","author":"Klunk","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Manook, A., Yousefi, B.H., Willuweit, A., Platzer, S., Reder, S., Voss, A., Huisman, M., Settles, M., Neff, F., and Velden, J. (2012). Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP\/PS1 mouse model of Alzheimer\u2019s disease. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031310"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/nm.3734","article-title":"Longitudinal PET-MRI reveals \u03b2-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion","volume":"20","author":"Maier","year":"2014","journal-title":"Nat. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11307-013-0625-z","article-title":"Voxel-based analysis of amyloid-burden measured with [11C]PiB PET in a double transgenic mouse model of Alzheimer\u2019s disease","volume":"15","author":"Yousefi","year":"2013","journal-title":"Mol. Imaging Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13195-015-0158-6","article-title":"In vivo molecular neuroimaging of glucose utilization and its association with fibrillar amyloid-\u03b2 load in aged APPPS1-21 mice","volume":"7","author":"Waldron","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1093\/hmg\/ddz045","article-title":"A longitudinal multimodal in vivo molecular imaging study of the 3xTg-AD mouse model shows progressive early hippocampal and taurine loss","volume":"28","author":"Chiquita","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1523\/JNEUROSCI.0673-07.2007","article-title":"Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer\u2019s disease enabled by positron emission tomography","volume":"27","author":"Maeda","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/syn.21842","article-title":"Comparing \u03b17 nicotinic acetylcholine receptor binding, amyloid-\u03b2 deposition, and mitochondria complex-I function in living brain: A PET study in aged monkeys","volume":"69","author":"Nishiyama","year":"2015","journal-title":"Synapse"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s00259-014-2821-8","article-title":"Comparing amyloid-\u03b2 deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: A PET study in aged monkeys","volume":"41","author":"Tsukada","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"10379","DOI":"10.1038\/s41598-020-67284-z","article-title":"Hybrid PET\/MRI enables high-spatial resolution, quantitative imaging of amyloid plaques in an Alzheimer\u2019s disease mouse model","volume":"10","author":"Frost","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3233\/JAD-160760","article-title":"Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model","volume":"55","author":"Waldron","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.neurobiolaging.2011.12.024","article-title":"PET imaging with [18F]AV-45 in an APP\/PS1-21 murine model of amyloid plaque deposition","volume":"33","author":"Poisnel","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2967\/jnumed.120.242750","article-title":"Asymmetry of fibrillar plaque burden in amyloid mouse models","volume":"61","author":"Sacher","year":"2020","journal-title":"J. Nucl. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2967\/jnumed.112.114660","article-title":"Longitudinal assessment of cerebral \u03b2-amyloid deposition in mice overexpressing Swedish mutant \u03b2-amyloid precursor protein using 18F-florbetaben PET","volume":"54","author":"Rominger","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.2967\/jnumed.119.227322","article-title":"Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-\u03b2 Mouse Model","volume":"60","author":"Sacher","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"117707","DOI":"10.1016\/j.neuroimage.2020.117707","article-title":"Microglial activation in the right amygdala-entorhinal-hippocampal complex is associated with preserved spatial learning in App(NL-G-F) mice","volume":"230","author":"Biechele","year":"2021","journal-title":"Neuroimage"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12974-020-02046-2","article-title":"Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases","volume":"17","author":"Biechele","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12974-018-1347-6","article-title":"Microglial response to increasing amyloid load saturates with aging: A longitudinal dual tracer in vivo \u03bcPET-study","volume":"15","author":"Blume","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.7150\/thno.56059","article-title":"Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: A collaborative multi-modal study","volume":"11","author":"Chaney","year":"2021","journal-title":"Theranostics"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3389\/fmed.2020.00529","article-title":"In vivo Imaging With 18F-FDG- and 18F-Florbetaben-PET\/MRI Detects Pathological Changes in the Brain of the Commonly Used 5XFAD Mouse Model of Alzheimer\u2019s Disease","volume":"7","author":"Franke","year":"2020","journal-title":"Front. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00259-015-3047-0","article-title":"Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: A correlative positron emission tomography and in vitro imaging study","volume":"42","author":"Ni","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1471-4159.2008.05861.x","article-title":"AZD2184: A radioligand for sensitive detection of beta-amyloid deposits","volume":"108","author":"Johnson","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2967\/jnumed.106.037556","article-title":"2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: A novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer\u2019s disease patients","volume":"48","author":"Kudo","year":"2007","journal-title":"J. Nucl. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11307-012-0608-5","article-title":"A 18F-Labeled BF-227 Derivative as a Potential Radioligand for Imaging Dense Amyloid Plaques by Positron Emission Tomography","volume":"15","author":"Furumoto","year":"2013","journal-title":"Mol. Imaging Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"35636","DOI":"10.1038\/srep35636","article-title":"Fluselenamyl: A Novel Benzoselenazole Derivative for PET Detection of Amyloid Plaques (A\u03b2) in Alzheimer\u2019s Disease","volume":"6","author":"Sundaram","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"10759","DOI":"10.1038\/ncomms10759","article-title":"Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer\u2019s disease","volume":"7","author":"Sehlin","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1039\/C6SC04798J","article-title":"Highly specific noninvasive photoacoustic and positron emission tomography of brain plaque with functionalized croconium dye labeled by a radiotracer","volume":"8","author":"Liu","year":"2017","journal-title":"Chem. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","article-title":"Evidence for brain glucose dysregulation in Alzheimer\u2019s disease","volume":"14","author":"An","year":"2018","journal-title":"Alzheimer Dement."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/brain\/awm177","article-title":"FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer\u2019s disease","volume":"130","author":"Foster","year":"2007","journal-title":"Brain"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fnagi.2018.00425","article-title":"18F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4-42 Model of Alzheimer\u2019s Disease","volume":"10","author":"Bouter","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s11307-009-0198-z","article-title":"Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer\u2019s disease","volume":"11","author":"Kuntner","year":"2009","journal-title":"Mol. Imaging Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e12873","DOI":"10.1111\/acel.12873","article-title":"Temporal and regional progression of Alzheimer\u2019s disease-like pathology in 3xTg-AD mice","volume":"18","author":"Belfiore","year":"2019","journal-title":"Aging Cell"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nbd.2019.03.008","article-title":"Regional hypometabolism in the 3xTg mouse model of Alzheimer\u2019s disease","volume":"127","author":"Adlimoghaddam","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fmed.2019.00071","article-title":"18F-FDG-PET in Mouse Models of Alzheimer\u2019s Disease","volume":"6","author":"Bouter","year":"2019","journal-title":"Front. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1038\/s41598-019-42074-4","article-title":"Effect of genotype and age on cerebral [18F]FDG uptake varies between transgenic APPSwe-PS1dE9 and Tg2576 mouse models of Alzheimer\u2019s disease","volume":"9","author":"Snellman","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"eabe5640","DOI":"10.1126\/scitranslmed.abe5640","article-title":"Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases","volume":"13","author":"Xiang","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.brainres.2010.05.084","article-title":"Regional cerebral glucose uptake in the 3xTG model of Alzheimer\u2019s disease highlights common regional vulnerability across AD mouse models","volume":"1347","author":"Nicholson","year":"2010","journal-title":"Brain Res."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Sancheti, H., Akopian, G., Yin, F., Brinton, R.D., Walsh, J.P., and Cadenas, E. (2013). Age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic acid on a mouse model of Alzheimer\u2019s disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0069830"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.neurobiolaging.2010.08.005","article-title":"Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: Limitations as a translatable model of Alzheimer\u2019s disease","volume":"33","author":"Luo","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.expneurol.2017.01.013","article-title":"Neurovascular uncoupling in the triple transgenic model of Alzheimer\u2019s disease: Impaired cerebral blood flow response to neuronal-derived nitric oxide signaling","volume":"291","author":"Ledo","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"134938","DOI":"10.1016\/j.neulet.2020.134938","article-title":"Multi-target PET evaluation in APP\/PS1\/tau mouse model of Alzheimer\u2019s disease","volume":"728","author":"Liu","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"585476","DOI":"10.3389\/fnins.2020.585476","article-title":"Electroacupuncture Protects Cognition by Regulating Tau Phosphorylation and Glucose Metabolism via the AKT\/GSK3\u03b2 Signaling Pathway in Alzheimer\u2019s Disease Model Mice","volume":"14","author":"Xu","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.neurobiolaging.2011.09.026","article-title":"Increased regional cerebral glucose uptake in an APP\/PS1 model of Alzheimer\u2019s disease","volume":"33","author":"Poisnel","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1177\/0271678X16677990","article-title":"Brain energy metabolism and neuroinflammation in ageing APP\/PS1-21 mice using longitudinal 18F-FDG and 18F-DPA-714 PET imaging","volume":"37","author":"Takkinen","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s42003-020-01584-y","article-title":"Partial inhibition of mitochondrial complex I ameliorates Alzheimer\u2019s disease pathology and cognition in APP\/PS1 female mice","volume":"4","author":"Stojakovic","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fnbeh.2019.00107","article-title":"Analysis of Motor Function in the Tg4-42 Mouse Model of Alzheimer\u2019s Disease","volume":"13","author":"Wagner","year":"2019","journal-title":"Front. Behav. Neurosci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2174\/1567205011666140505111354","article-title":"Early detection of cerebral glucose uptake changes in the 5XFAD mouse","volume":"11","author":"Macdonald","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12974-021-02244-6","article-title":"Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer\u2019s disease","volume":"18","author":"Choi","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.nbd.2011.05.003","article-title":"[F-18]FDDNP microPET imaging correlates with brain A\u03b2 burden in a transgenic rat model of Alzheimer disease: Effects of aging, in vivo blockade, and anti-A\u03b2 antibody treatment","volume":"43","author":"Teng","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1007\/s00259-007-0710-0","article-title":"Imaging noradrenergic influence on amyloid pathology in mouse models of Alzheimer\u2019s disease","volume":"35","author":"Winkeler","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Deleye, S., Waldron, A.M., Richardson, J.C., Schmidt, M., Langlois, X., Stroobants, S., and Staelens, S. (2016). The Effects of Physiological and Methodological Determinants on 18F-FDG Mouse Brain Imaging Exemplified in a Double Transgenic Alzheimer Model. Mol. Imaging, 15.","DOI":"10.1177\/1536012115624919"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.2967\/jnumed.118.223867","article-title":"In Vivo Synaptic Density Imaging with 11C-UCB-J Detects Treatment Effects of Saracatinib in a Mouse Model of Alzheimer Disease","volume":"60","author":"Toyonaga","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"118302","DOI":"10.1016\/j.neuroimage.2021.118302","article-title":"In vivo imaging of synaptic density with [11C]UCB-J PET in two mouse models of neurodegenerative disease","volume":"239","author":"Xiong","year":"2021","journal-title":"NeuroImage"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11307-020-01567-9","article-title":"Quantification of SV2A Binding in Rodent Brain Using [18F]SynVesT-1 and PET Imaging","volume":"23","author":"Sadasivam","year":"2021","journal-title":"Mol. Imaging Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neurobiolaging.2019.08.006","article-title":"Age dependency of mGluR5 availability in 5xFAD mice measured by PET","volume":"84","author":"Lee","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Son, Y., Jeong, Y.J., Shin, N.-R., Oh, S.J., Nam, K.R., Choi, H.-D., Choi, J.Y., and Lee, H.-J. (2020). Inhibition of Colony-Stimulating Factor 1 Receptor by PLX3397 Prevents Amyloid Beta Pathology and Rescues Dopaminergic Signaling in Aging 5xFAD Mice. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155553"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Varlow, C., Murrell, E., Holland, J.P., Kassenbrock, A., Shannon, W., Liang, S.H., Vasdev, N., and Stephenson, N.A. (2020). Revisiting the Radiosynthesis of [18F]FPEB and Preliminary PET Imaging in a Mouse Model of Alzheimer\u2019s Disease. Molecules, 25.","DOI":"10.3390\/molecules25040982"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuropharm.2016.10.009","article-title":"Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [11C]ABP688 PET imaging and ex vivo immunoblotting","volume":"113","author":"Fang","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1523\/JNEUROSCI.4236-05.2006","article-title":"Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice","volume":"26","author":"Heneka","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.7150\/thno.54589","article-title":"Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease","volume":"11","author":"Rejc","year":"2021","journal-title":"Theranostics"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Chen, Y.A., Lu, C.H., Ke, C.C., Chiu, S.J., Chang, C.W., Yang, B.H., Gelovani, J.G., and Liu, R.S. (2021). Evaluation of Class IIa Histone Deacetylases Expression and In Vivo Epigenetic Imaging in a Transgenic Mouse Model of Alzheimer\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168633"},{"key":"ref_123","unstructured":"Satoru, Y., Yurika, I., Shunsuke, I., Takeharu, K., Hiroyuki, O., Shingo, N., Masakatsu, K., Hideo, T., Kohji, S., and Yasuomi, O. (2021). In Vivo elevation of mitochondrial activity and amyloid deposition, but inversely correlated, in early-stage senescence-accelerated mice: A positron emission tomography study. Res. Sq."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-021-00448-1","article-title":"Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer\u2019s disease","volume":"16","author":"Terada","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2967\/jnumed.115.162370","article-title":"PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer Disease","volume":"57","author":"Torres","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e037790","DOI":"10.1002\/alz.037790","article-title":"[11C]MPC-6827, a microtubule-based PET imaging tracer: A potential early imaging biomarker for AD and other ADRDs","volume":"16","author":"Sai","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"9600","DOI":"10.1021\/acs.jmedchem.9b01030","article-title":"Structural Basis for Achieving GSK-3\u03b2 Inhibition with High Potency, Selectivity, and Brain Exposure for Positron Emission Tomography Imaging and Drug Discovery","volume":"62","author":"Mossine","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Giglio, J., Fernandez, S., Martinez, A., Zeni, M., Reyes, L., Rey, A., and Cerecetto, H. (2021). Glycogen Synthase Kinase-3 Maleimide Inhibitors As Potential PET-Tracers for Imaging Alzheimer\u2019s Disease: 11C-Synthesis and In Vivo Proof of Concept. J. Med. Chem.","DOI":"10.1021\/acs.jmedchem.1c00769"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4155\/fmc-2019-0329","article-title":"Radiolabeling of [11C]FPS-ZM1, a receptor for advanced glycation end products-targeting positron emission tomography radiotracer, using a [11C]CO(2)-to-[11C]CO chemical conversion","volume":"12","author":"Luzi","year":"2020","journal-title":"Future Med. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1177\/0271678X19854541","article-title":"Measurement of cerebral ABCC1 transport activity in wild-type and APP\/PS1-21 mice with positron emission tomography","volume":"40","author":"Zoufal","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Wanek, T., Zoufal, V., Brackhan, M., Krohn, M., Mairinger, S., Filip, T., Sauberer, M., Stanek, J., Pekar, T., and Pahnke, J. (2020). Brain Distribution of Dual ABCB1\/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218245"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2967\/jnumed.119.237198","article-title":"Imaging P-Glycoprotein Induction at the Blood-Brain Barrier of a \u03b2-Amyloidosis Mouse Model with 11C-Metoclopramide PET","volume":"61","author":"Zoufal","year":"2020","journal-title":"J. Nucl. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/0271678X18806640","article-title":"Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET","volume":"40","author":"Zoufal","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2967\/jnumed.115.167858","article-title":"Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study","volume":"57","author":"Brendel","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: Correlation with cognitive severity","volume":"27","author":"DeKosky","year":"1990","journal-title":"Ann. Neurol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mcn.2019.02.001","article-title":"Synaptic vesicle protein 2A as a potential biomarker in synaptopathies","volume":"97","author":"Heurling","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"609908","DOI":"10.3389\/fcell.2021.609908","article-title":"The Synaptic Vesicle Protein 2A Interacts With Key Pathogenic Factors in Alzheimer\u2019s Disease: Implications for Treatment","volume":"9","author":"Kong","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","article-title":"Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"348ra396","DOI":"10.1126\/scitranslmed.aaf6667","article-title":"Imaging synaptic density in the living human brain","volume":"8","author":"Finnema","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Nowack, A., Malarkey, E.B., Yao, J., Bleckert, A., Hill, J., and Bajjalieh, S.M. (2011). Levetiracetam reverses synaptic deficits produced by overexpression of SV2A. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0029560"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.trci.2017.08.004","article-title":"Measuring brain synaptic vesicle protein 2A with positron emission tomography and [18F]UCB-H","volume":"3","author":"Bahri","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2967\/jnumed.120.249144","article-title":"First-in-Human Evaluation of 18F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A","volume":"62","author":"Naganawa","year":"2021","journal-title":"J. Nucl. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1021\/acschemneuro.8b00526","article-title":"Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates","volume":"10","author":"Li","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11307-018-1260-5","article-title":"Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers","volume":"21","author":"Constantinescu","year":"2019","journal-title":"Mol. Imaging Biol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13195-020-00742-y","article-title":"Association of A\u03b2 deposition and regional synaptic density in early Alzheimer\u2019s disease: A PET imaging study with [11C]UCB-J","volume":"13","author":"Mecca","year":"2021","journal-title":"Alzheimer Res. Ther."},{"key":"ref_147","first-page":"0271678X1986408","article-title":"Validation and noninvasive kinetic modeling of [11C]UCB-J PET imaging in mice","volume":"40","author":"Bertoglio","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1021\/acschemneuro.9b00618","article-title":"Synthesis and Preclinical Evaluation of an 18F-Labeled Synaptic Vesicle Glycoprotein 2A PET Imaging Probe: [18F]SynVesT-2","volume":"11","author":"Cai","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nrn.2017.24","article-title":"NMDA receptors: Linking physiological output to biophysical operation","volume":"18","author":"Iacobucci","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nrn916","article-title":"Beyond the role of glutamate as a neurotransmitter","volume":"3","author":"Nedergaard","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of Glutamate and NMDA Receptors in Alzheimer\u2019s Disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nn0805-977","article-title":"The synaptic Abeta hypothesis of Alzheimer disease","volume":"8","author":"Tanzi","year":"2005","journal-title":"Nat. Neurosci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","article-title":"Regulation of NMDA receptor trafficking by amyloid-beta","volume":"8","author":"Snyder","year":"2005","journal-title":"Nat. Neurosci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"Shankar","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","article-title":"Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer A\u03b2 Oligomer Bound to Cellular Prion Protein","volume":"79","author":"Um","year":"2013","journal-title":"Neuron"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"E6526","DOI":"10.1073\/pnas.1614249113","article-title":"Amyloid-\u03b2 effects on synapses and memory require AMPA receptor subunit GluA3","volume":"113","author":"Reinders","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_158","first-page":"797","article-title":"Amyloid-\u03b2 oligomers suppress subunit-specific glutamate receptor increase during LTP","volume":"5","author":"Tanaka","year":"2019","journal-title":"Alzheimers Dement."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1126\/science.aay0198","article-title":"A vicious cycle of \u03b2 amyloid-dependent neuronal hyperactivation","volume":"365","author":"Zott","year":"2019","journal-title":"Science"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.celrep.2016.04.077","article-title":"Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model","volume":"15","author":"Hamilton","year":"2016","journal-title":"Cell Rep."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41591-019-0723-9","article-title":"Visualization of AMPA receptors in living human brain with positron emission tomography","volume":"26","author":"Miyazaki","year":"2020","journal-title":"Nat. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13550-017-0313-0","article-title":"A human PET study of [11C]HMS011, a potential radioligand for AMPA receptors","volume":"7","author":"Takahata","year":"2017","journal-title":"EJNMMI Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1177\/0271678X20954928","article-title":"NMDA receptor ion channel activation detected in vivo with [18F]GE-179 PET after electrical stimulation of rat hippocampus","volume":"41","author":"Vibholm","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-018-0424-2","article-title":"First in human evaluation of [18F]PK-209, a PET ligand for the ion channel binding site of NMDA receptors","volume":"8","author":"Golla","year":"2018","journal-title":"EJNMMI Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2967\/jnumed.117.200451","article-title":"Evaluation of 11C-Me-NB1 as a Potential PET Radioligand for Measuring GluN2B-Containing NMDA Receptors, Drug Occupancy, and Receptor Cross Talk","volume":"59","author":"Betzel","year":"2018","journal-title":"J. Nucl. Med."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Abd-Elrahman, K.S., Albaker, A., de Souza, J.M., Ribeiro, F.M., Schlossmacher, M.G., Tiberi, M., Hamilton, A., and Ferguson, S.S.G. (2020). A\u03b2 oligomers induce pathophysiological mGluR5 signaling in Alzheimer\u2019s disease model mice in a sex-selective manner. Sci. Signal, 13.","DOI":"10.1126\/scisignal.abd2494"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2967\/jnumed.112.107995","article-title":"18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: A first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry","volume":"54","author":"Wong","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_168","first-page":"698","article-title":"Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5","volume":"47","author":"Ametamey","year":"2006","journal-title":"J. Nucl. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00259-017-3879-x","article-title":"A first-in-man PET study of [18F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5","volume":"45","author":"Warnock","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13195-020-0582-0","article-title":"PET imaging of mGluR5 in Alzheimer\u2019s disease","volume":"12","author":"Mecca","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"e01632","DOI":"10.1002\/brb3.1632","article-title":"Reduced uptake of [11C]-ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer\u2019s dementia","volume":"10","author":"Treyer","year":"2020","journal-title":"Brain Behav."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0006-3223(00)01125-2","article-title":"Nicotinic receptor abnormalities of Alzheimer\u2019s disease: Therapeutic implications","volume":"49","author":"Nordberg","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","article-title":"Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation","volume":"421","author":"Wang","year":"2003","journal-title":"Nature"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"S491","DOI":"10.1186\/1742-2094-10-90","article-title":"H-3-Deprenyl and H-3-PIB autoradiography show different laminar distributions of astroglia and fibrillar beta-amyloid in Alzheimer brain","volume":"10","author":"Marutle","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archneurol.2009.46","article-title":"Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease","volume":"66","author":"Ikonomovic","year":"2009","journal-title":"Arch. Neurol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"fcaa058","DOI":"10.1093\/braincomms\/fcaa058","article-title":"M1 muscarinic acetylcholine receptor dysfunction in moderate Alzheimer\u2019s disease pathology","volume":"2","author":"Yi","year":"2020","journal-title":"Brain Commun."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3233\/JAD-2012-121447","article-title":"Modulation of \u03b17 nicotinic acetylcholine receptor and fibrillar amyloid-\u03b2 interactions in Alzheimer\u2019s disease brain","volume":"33","author":"Ni","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1523\/JNEUROSCI.6088-08.2009","article-title":"Dissociating beta-amyloid from alpha 7 nicotinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes alpha 7 nicotinic acetylcholine and NMDA receptor function in Alzheimer\u2019s disease brain","volume":"29","author":"Wang","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajpath.2013.10.010","article-title":"\u03b17 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles","volume":"184","author":"Medeiros","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1523\/JNEUROSCI.0876-20.2020","article-title":"Implications of Oligomeric Amyloid-Beta (oA\u03b2(42)) Signaling through \u03b17\u03b22-Nicotinic Acetylcholine Receptors (nAChRs) on Basal Forebrain Cholinergic Neuronal Intrinsic Excitability and Cognitive Decline","volume":"41","author":"George","year":"2021","journal-title":"J. Neurosci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2967\/jnumed.111.088815","article-title":"11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: In vivo evaluation and drug occupancy measurements","volume":"52","author":"Ettrup","year":"2011","journal-title":"J. Nucl. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1021\/jm401184f","article-title":"Derivatives of dibenzothiophene for positron emission tomography imaging of \u03b17-nicotinic acetylcholine receptors","volume":"56","author":"Gao","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/npp.2011.31","article-title":"Muscarinic Receptor Occupancy and Cognitive Impairment: A PET Study with [11C](+)3-MPB and Scopolamine in Conscious Monkeys","volume":"36","author":"Yamamoto","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"111354","DOI":"10.1016\/j.pscychresns.2021.111354","article-title":"PET Imaging of brain muscarinic receptors with 18F-Fluorobenzyl-Dexetimide: A first in human study","volume":"316","author":"Rowe","year":"2021","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2967\/jnumed.118.222034","article-title":"Evaluation of 11C-LSN3172176 as a Novel PET Tracer for Imaging M(1) Muscarinic Acetylcholine Receptors in Nonhuman Primates","volume":"60","author":"Nabulsi","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1021\/acs.jmedchem.9b01406","article-title":"Discovery of [11C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases","volume":"63","author":"Tong","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00213-006-0447-7","article-title":"PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer\u2019s disease","volume":"188","author":"Kadir","year":"2006","journal-title":"Psychopharmacology"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-021-00073-z","article-title":"APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer\u2019s mice via cyclophilin A independently of amyloid-\u03b2","volume":"1","author":"Montagne","year":"2021","journal-title":"Nat. Aging"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuron.2015.09.036","article-title":"Lack of Widespread BBB Disruption in Alzheimer\u2019s Disease Models: Focus on Therapeutic Antibodies","volume":"88","author":"Boswell","year":"2015","journal-title":"Neuron"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00401-011-0834-y","article-title":"Vascular \u03b2-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcA\u03b2 mice","volume":"122","author":"Merlini","year":"2011","journal-title":"Acta Neuropathol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0271678X16679420","article-title":"Age-associated physiological and pathological changes at the blood-brain barrier: A review","volume":"37","author":"Denes","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Mossel, P., Garcia Varela, L., Arif, W.M., van der Weijden, C.W.J., Boersma, H.H., Willemsen, A.T.M., Boellaard, R., Elsinga, P.H., Borra, R.J.H., and Colabufo, N.A. (2021). Evaluation of P-glycoprotein function at the blood-brain barrier using [18F]MC225-PET. Eur. J. Nucl. Med. Mol. Imaging, 1\u20132.","DOI":"10.1007\/s00259-021-05419-8"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1021\/acschemneuro.7b00086","article-title":"Synthesis and Evaluation of New Fluorine-18 Labeled Verapamil Analogs To Investigate the Function of P-Glycoprotein in the Blood-Brain Barrier","volume":"8","author":"Raaphorst","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1021\/acs.molpharmaceut.0c00514","article-title":"Pharmacokinetic Modeling of [18F]MC225 for Quantification of the P-Glycoprotein Function at the Blood\u2013Brain Barrier in Non-Human Primates with PET","volume":"17","author":"Arif","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1177\/0271678X16654493","article-title":"Evaluation of [18F]MC225 as a PET radiotracer for measuring P-glycoprotein function at the blood-brain barrier in rats: Kinetics, metabolism, and selectivity","volume":"37","author":"Savolainen","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-4889(00)00087-2","article-title":"The biology of the receptor for advanced glycation end products and its ligands","volume":"1498","author":"Schmidt","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"ref_201","first-page":"1049","article-title":"RAGE-specific probe 18F -FPS-ZM1 may be a promising biomarker for early detection of Diabetes with Alzheimer\u2019s disease","volume":"57","author":"Kong","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/acschemneuro.5b00319","article-title":"Synthesis and Evaluation of [18F]RAGER: A First Generation Small-Molecule PET Radioligand Targeting the Receptor for Advanced Glycation Endproducts","volume":"7","author":"Cary","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jpha.2020.07.009","article-title":"Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)","volume":"10","author":"Drake","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.7150\/thno.24791","article-title":"Multimodal imaging of the receptor for advanced glycation end-products with molecularly targeted nanoparticles","volume":"8","author":"Konopka","year":"2018","journal-title":"Theranostics"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1474-4422(20)30346-X","article-title":"PET imaging of neuroinflammation in neurological disorders","volume":"19","author":"Kreisl","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/bs.pmbts.2019.04.005","article-title":"Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer\u2019s disease","volume":"165","author":"Janssen","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Van Camp, N., Lavisse, S., Roost, P., Gubinelli, F., Hillmer, A., and Boutin, H. (2021). TSPO imaging in animal models of brain diseases. Eur. J. Nucl. Med. Mol. Imaging, 1\u201333.","DOI":"10.1007\/s00259-021-05379-z"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"e2944","DOI":"10.1212\/WNL.0000000000012109","article-title":"Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis","volume":"96","author":"Bellaver","year":"2021","journal-title":"Neurology"},{"key":"ref_210","first-page":"3750","article-title":"PET Imaging of Neuroinflammation in Alzheimer\u2019s Disease","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","article-title":"Microglial activation and tau propagate jointly across Braak stages","volume":"27","author":"Pascoal","year":"2021","journal-title":"Nat. Med."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","article-title":"Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques","volume":"22","author":"Huang","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease","volume":"169","author":"Spinrad","year":"2017","journal-title":"Cell"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41590-018-0212-1","article-title":"The identity and function of microglia in neurodegeneration","volume":"19","author":"Song","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.neurobiolaging.2007.11.005","article-title":"PK11195 labels activated microglia in Alzheimer\u2019s disease and in vivo in a mouse model using PET","volume":"30","author":"Venneti","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/glia.22978","article-title":"In vivo imaging of microglial activation by positron emission tomography with [11C]PBR28 in the 5XFAD model of Alzheimer\u2019s disease","volume":"64","author":"Mirzaei","year":"2016","journal-title":"Glia"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2967\/jnumed.116.178996","article-title":"11C-ER176, a Radioligand for 18-kDa Translocator Protein, Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain","volume":"58","author":"Ikawa","year":"2017","journal-title":"J. Nucl. Med."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Wright, A.L., Zinn, R., Hohensinn, B., Konen, L.M., Beynon, S.B., Tan, R.P., Clark, I.A., Abdipranoto, A., and Vissel, B. (2013). Neuroinflammation and Neuronal Loss Precede A\u03b2 Plaque Deposition in the hAPP-J20 Mouse Model of Alzheimer\u2019s Disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059586"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2967\/jnumed.117.197608","article-title":"Neuroinflammation Appears Early on PET Imaging and Then Plateaus in a Mouse Model of Alzheimer Disease","volume":"59","author":"Snellman","year":"2018","journal-title":"J. Nucl. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fnagi.2017.00008","article-title":"Increase of TREM2 during Aging of an Alzheimer\u2019s Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis","volume":"9","author":"Brendel","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2967\/jnumed.118.217703","article-title":"Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP Mice","volume":"60","author":"Focke","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2967\/jnumed.118.209155","article-title":"11C-DPA-713 Versus 18F-GE-180: A Preclinical Comparison of Translocator Protein 18 kDa PET Tracers to Visualize Acute and Chronic Neuroinflammation in a Mouse Model of Ischemic Stroke","volume":"60","author":"Chaney","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Ji, B., Ono, M., Yamasaki, T., Fujinaga, M., Zhang, M.R., Seki, C., Aoki, I., Kito, S., Sawada, M., and Suhara, T. (2021). Detection of Alzheimer\u2019s disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein. J. Cereb. Blood Flow Metab., 271678x21992457.","DOI":"10.1177\/0271678X21992457"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/cei.13649","article-title":"Toward PET imaging of the dynamic phenotypes of microglia","volume":"206","author":"Beaino","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Ni, R., M\u00fcller Herde, A., Haider, A., Keller, C., Louloudis, G., Vaas, M., Schibli, R., Ametamey, S.M., Klohs, J., and Mu, L. (2021). In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI. bioRxiv.","DOI":"10.1101\/2021.05.08.441033"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00259-019-04550-x","article-title":"The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: A first-in man study","volume":"47","author":"Hagens","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1038\/s41598-018-24814-0","article-title":"Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation","volume":"8","author":"Janssen","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"fcab011","DOI":"10.1093\/braincomms\/fcab011","article-title":"Distinct microglial response against Alzheimer\u2019s amyloid and tau pathologies characterized by P2Y12 receptor","volume":"3","author":"Maeda","year":"2021","journal-title":"Brain Commun."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1073\/pnas.1812155116","article-title":"PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R)","volume":"116","author":"Horti","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Zhou, X., Ji, B., Seki, C., Nagai, Y., Minamimoto, T., Fujinaga, M., Zhang, M.R., Saito, T., Saido, T.C., and Suhara, T. (2021). PET imaging of colony-stimulating factor 1 receptor: A head-to-head comparison of a novel radioligand, 11C-GW2580, and 11C-CPPC, in mouse models of acute and chronic neuroinflammation and a rhesus monkey. J. Cereb. Blood Flow Metab., 271678x211004146.","DOI":"10.1177\/0271678X211004146"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2967\/jnumed.115.166116","article-title":"Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer\u2019s Disease Model Mice","volume":"57","author":"Shukuri","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Meier, S.R., Sehlin, D., Hultqvist, G., and Syv\u00e4nen, S. (2021). Pinpointing Brain TREM2 Levels in Two Mouse Models of Alzheimer\u2019s Disease. Mol. Imaging Biol., 1\u201311.","DOI":"10.1007\/s11307-021-01591-3"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/0271678X20931140","article-title":"In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET","volume":"41","author":"Thomsen","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/brain\/awx120","article-title":"Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer\u2019s disease","volume":"140","author":"Parbo","year":"2017","journal-title":"Brain"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/acschemneuro.7b00385","article-title":"Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in Neuroinflammation","volume":"9","author":"Hou","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1038\/s41467-021-24900-4","article-title":"Endo-lysosomal A\u03b2 concentration and pH trigger formation of A\u03b2 oligomers that potently induce Tau missorting","volume":"12","author":"Hasecke","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1021\/acs.jmedchem.8b00028","article-title":"Radiosynthesis and in Vivo Evaluation of [11C]MPC-6827, the First Brain Penetrant Microtubule PET Ligand","volume":"61","author":"Kumar","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1021\/acsmedchemlett.8b00060","article-title":"Radiosynthesis and Evaluation of [11C]HD-800, a High Affinity Brain Penetrant PET Tracer for Imaging Microtubules","volume":"9","author":"Prabhakaran","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2967\/jnumed.116.188052","article-title":"PET Imaging Evaluation of Four \u03c3(1) Radiotracers in Nonhuman Primates","volume":"58","author":"Baum","year":"2017","journal-title":"J. Nucl. Med."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"7938","DOI":"10.7150\/thno.47585","article-title":"Evaluation of 18F-IAM6067 as a sigma-1 receptor PET tracer for neurodegeneration in vivo in rodents and in human tissue","volume":"10","author":"Lepelletier","year":"2020","journal-title":"Theranostics"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.apsb.2019.07.002","article-title":"Novel radioligands for imaging sigma-1 receptor in brain using positron emission tomography (PET)","volume":"9","author":"Lan","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1021\/acsptsci.1c00132","article-title":"In Vitro and In Vivo Evaluation of GSK-3 Radioligands in Alzheimer\u2019s Disease: Preliminary Evidence of Sex Differences","volume":"4","author":"Knight","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/s41593-019-0486-0","article-title":"Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration","volume":"22","author":"Joshi","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.it.2020.07.005","article-title":"Immunological Features of Non-neuronal Brain Cells: Implications for Alzheimer\u2019s Disease Immunotherapy","volume":"41","author":"Castellani","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-021-03734-6","article-title":"Astrocytic interleukin-3 programs microglia and limits Alzheimer\u2019s disease","volume":"595","author":"McAlpine","year":"2021","journal-title":"Nature"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"eaba3239","DOI":"10.1126\/sciadv.aba3239","article-title":"Astrocytes and microglia play orchestrated roles and respect phagocytic territories during neuronal corpse removal in vivo","volume":"6","author":"Damisah","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","article-title":"Disease-associated astrocytes in Alzheimer\u2019s disease and aging","volume":"23","author":"Habib","year":"2020","journal-title":"Nat. Neurosci."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s11307-017-1153-z","article-title":"Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer\u2019s Disease","volume":"20","author":"Olsen","year":"2018","journal-title":"Mol. Imaging Biol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2967\/jnumed.120.244400","article-title":"18F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging","volume":"62","author":"Harada","year":"2021","journal-title":"J. Nucl. Med."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"108676","DOI":"10.1016\/j.neuropharm.2021.108676","article-title":"(S)-[18F]THK5117 brain uptake is associated with A\u03b2 plaques and MAO-B enzyme in a mouse model of Alzheimer\u2019s disease","volume":"196","author":"Alzghool","year":"2021","journal-title":"Neuropharmacology"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"128254","DOI":"10.1016\/j.bmcl.2021.128254","article-title":"In vitro and in vivo evaluation of fluorinated indanone derivatives as potential positron emission tomography agents for the imaging of monoamine oxidase B in the brain","volume":"48","author":"Toussaint","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Kumar, A., Koistinen, N.A., Malarte, M.-L., Nennesmo, I., Ingelsson, M., Ghetti, B., Lemoine, L., and Nordberg, A. (2021). Astroglial tracer BU99008 detects multiple binding sites in Alzheimer\u2019s disease brain. Mol. Psychiatry, 1\u201315.","DOI":"10.1038\/s41380-021-01101-5"},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Livingston, N.R., Calsolaro, V., Hinz, R., Nowell, J., Raza, S., Gentleman, S., Tyacke, R.J., Myers, J., Venkataraman, A.V., and Perneczky, R. (2021). Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals. medRxiv.","DOI":"10.1101\/2021.08.10.21261690"},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Calsolaro, V., Matthews, P.M., Donat, C.K., Livingston, N.R., Femminella, G.D., Guedes, S.S., Myers, J., Fan, Z., Tyacke, R.J., and Venkataraman, A.V. (2021). Astrocyte reactivity with late-onset cognitive impairment assessed in vivo using 11C-BU99008 PET and its relationship with amyloid load. Mol. Psychiatry, 1\u20138.","DOI":"10.1038\/s41380-021-01193-z"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2967\/jnumed.117.201632","article-title":"Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models","volume":"59","author":"Ni","year":"2018","journal-title":"J. Nucl. Med."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3233\/JAD-170509","article-title":"In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510","volume":"61","author":"Ishikawa","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pacs.2018.04.001","article-title":"Cortical hypoperfusion and reduced cerebral metabolic rate of oxygen in the arcA\u03b2 mouse model of Alzheimer\u2019s disease","volume":"10","author":"Ni","year":"2018","journal-title":"Photoacoustics"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13195-020-00588-4","article-title":"The clinical promise of biomarkers of synapse damage or loss in Alzheimer\u2019s disease","volume":"12","author":"Zetterberg","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuron.2018.11.040","article-title":"Harnessing Genetic Complexity to Enhance Translatability of Alzheimer\u2019s Disease Mouse Models: A Path toward Precision Medicine","volume":"101","author":"Neuner","year":"2019","journal-title":"Neuron"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41586-019-1506-7","article-title":"Conserved cell types with divergent features in human versus mouse cortex","volume":"573","author":"Hodge","year":"2019","journal-title":"Nature"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neurobiolaging.2016.04.019","article-title":"Comparative pathobiology of \u03b2-amyloid and the unique susceptibility of humans to Alzheimer\u2019s disease","volume":"44","author":"Rosen","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"e12114","DOI":"10.1002\/trc2.12114","article-title":"Translational animal models for Alzheimer\u2019s disease: An Alzheimer\u2019s Association Business Consortium Think Tank","volume":"6","author":"Vitek","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_267","first-page":"e12110","article-title":"Model organism development and evaluation for late-onset Alzheimer\u2019s disease: MODEL-AD","volume":"6","author":"Oblak","year":"2020","journal-title":"Alzheimers Dement."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13024-020-00412-5","article-title":"A novel systems biology approach to evaluate mouse models of late-onset Alzheimer\u2019s disease","volume":"15","author":"Preuss","year":"2020","journal-title":"Mol. Neurodegener."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/11\/1179\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:31:56Z","timestamp":1760167916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/11\/1179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":268,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ph14111179"],"URL":"https:\/\/doi.org\/10.3390\/ph14111179","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]}}}